Assessment of pharmacokinetic drug-drug interaction between pradigastat and acetaminophen in healthy subjects

被引:0
|
作者
Surya Ayalasomayajula
Dan Meyers
Phillip Koo
Atish Salunke
Tapan Majumdar
Sam Rebello
Gangadhar Sunkara
Jin Chen
机构
[1] Novartis Institutes for BioMedical Research,
[2] Novartis Institutes for BioMedical Research,undefined
[3] Novartis Healthcare Pvt. Ltd,undefined
关键词
Pharmacokinetics; Drug-drug interaction; Pradigastat; Acetaminophen; Gastric motility;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:425 / 432
页数:7
相关论文
共 50 条
  • [41] Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin
    Mück W.
    Adelmann H.-G.
    Ruf T.
    Unger S.
    Voith B.
    Clinical Drug Investigation, 2000, 19 (1) : 71 - 73
  • [42] Pharmacokinetic drug-drug interaction study between raltegravir and citalopram
    Blonk, Maren I.
    Langemeijer, Charlotte C. A.
    Colbers, Angela P. H.
    Hoogtanders, Karin E. J.
    van Schaik, Ron H. N.
    Schouwenberg, Bas J. J. W.
    ANTIVIRAL THERAPY, 2016, 21 (02) : 143 - 152
  • [43] No relevant pharmacokinetic drug-drug interaction between nintedanib and pirfenidone
    Richeldi, Luca
    Fletcher, Sophie
    Adamali, Huzaifa
    Chaudhuri, Nazia
    Wiebe, Sabrina
    Wind, Sven
    Hohl, Kathrin
    Baker, Andrew
    Schlenker-Herceg, Rozsa
    Stowasser, Susanne
    Maher, Toby M.
    EUROPEAN RESPIRATORY JOURNAL, 2019, 53 (01)
  • [44] Lack of pharmacokinetic drug-drug interaction between ciclesonide and erythromycin
    Nave, R
    Drollmann, A
    Steinijans, VW
    Zech, K
    Bethke, TD
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2005, 43 (06) : 264 - 270
  • [45] Absence of pharmacokinetic drug-drug interaction between telbivudine and tenofovir
    Zhou, Xiao-Jian
    Pietropaolo, Keith
    Becker, Maya
    Ke, June
    Brown, Nathaniel A.
    GASTROENTEROLOGY, 2007, 132 (04) : A766 - A766
  • [46] Lack of pharmacokinetic drug-drug interaction between orlistat and cerivastatin
    Mück, W
    Adelmann, HG
    Ruf, T
    Unger, S
    Voith, B
    CLINICAL DRUG INVESTIGATION, 2000, 19 (01) : 71 - 73
  • [47] An assessment of Drug-Drug interaction: the effect of desvenlafaxine succinate and Duloxetine on the pharmacokinetics of desipramine in healthy subjects
    Patroneva, A.
    Connolly, S.
    Fatato, P.
    Nichols, A.
    Paul, J.
    Guico-Pabia, C.
    INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2007, 11 (04) : 334 - 335
  • [48] Pharmacokinetics and Drug-Drug Interaction of KBP-5074 in Healthy Subjects
    Wang, Ping
    Liu Jinrong
    Tan, Judy
    Zhang, Jay
    Yang, Y. Fred
    McCabe, James C.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 385 - 386
  • [49] DRUG-DRUG INTERACTION PROFILE OF TEZACAFTOR/ IVACAFTOR IN HEALTHY ADULT SUBJECTS
    Garg, V
    Shen, J.
    Li, C.
    Agarwal, S.
    Gebre, A.
    Parkinson, J.
    Robertson, S.
    Viswanathan, L.
    Huang, J.
    Han, L.
    Lekstrom-Himes, J.
    PEDIATRIC PULMONOLOGY, 2017, 52 : S310 - S310
  • [50] Drug-drug interaction studies with mirtazapine and carbamazepine in healthy male subjects
    J M A Sitsen
    F A Maris
    C J Timmer
    European Journal of Drug Metabolism and Pharmacokinetics, 2001, 26 : 109 - 121